Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CARGO Therapeutics, Inc. - Common Stock (NQ: CRGX )

12.04 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5
Open 12.04
Bid (Size) 4.830 (1)
Ask (Size) 14.88 (2)
Prev. Close 12.04
Today's Range 12.04 - 12.04
52wk Range 10.91 - 33.92
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Axsome Therapeutics, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga

Performance

YTD
-20.00%
-20.00%
1 Month
-16.97%
-16.97%
3 Month
-47.72%
-47.72%
6 Month
-31.67%
-31.67%
1 Year
-38.26%
-38.26%

More News

Read More
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CARGO Therapeutics to Participate in Upcoming Investor Conferences
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week
Via The Motley Fool
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
From Cargo Therapeutics, Inc.
Via GlobeNewswire
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Undiscovered Stocks on the Verge of a Breakout: 3 Names to Know Now
Via InvestorPlace
CARGO Therapeutics to Participate in Upcoming Investor Conferences
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q1 2024
Via InvestorPlace
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
From Cargo Therapeutics, Inc.
Via GlobeNewswire
CRGX Stock Earnings: Cargo Therapeutics Misses EPS for Q4 2023
Via InvestorPlace
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
From Cargo Therapeutics, Inc.
Via GlobeNewswire
IPO watch 2024: Which new stocks will hit the market?
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.